Additional Details
-
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SitePhoenix AZ. 85006View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteStanford CA. 94305View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteBirmingham AL. 35205View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteBoise ID. 83712View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteChampaign IL. 61820View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteLexington KY. 40536View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteSaint-Charles-Borromée QC. J6E 2B4View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteBaltimore MD. 21201View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteChicago IL. 60611View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteSacramento CA. 95817View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteLoma Linda CA. 92350View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SitePhoenix AZ. 85032View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SitePhiladelphia PA. 19140View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Research SiteKansas City KS. 66160View Details -
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
Maule Stem Cell Research InstituteVenice FL. 34292View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Alberta Children's HospitalCalgary AB. T3B 6A8View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Children's Hospital Los AngelesLos Angeles CA. 90027View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
University of MinnesotaMinneapolis MN. 55454View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Children's Hospital of PhiladelphiaPhiladelphia PA. 19104View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Johns Hopkins HospitalBaltimore MD. 21287View Details